Investor portrait

High-profile investor tracker

David Einhorn Portfolio

DME Capital Management Holdings

A filing-based view of DME Capital Management’s publicly disclosed U.S.-listed holdings, with portfolio concentration, quarter-over-quarter changes and verified SEC history.

SEC history uses the documented manager succession from Greenlight Capital Inc. to DME Capital Management, LP. This tracker reflects public Form 13F disclosures, not David Einhorn’s personal brokerage account or exact trade dates.

Confirmed SEC snapshot

$3.91B

Reported 13F value · Q2 2026

4613F entries
2026-08-14filing date
13F-HRsource filing
10verified quarters

Portfolio

GREEN BRICK PARTNERS INCGRBK
$757.8M
19.4%
+12.1%Est. vs filing basis
Unchanged
Reported shares9,467,383
Current price$67.50
SEC reference price$80.04
Estimated filing-based basis$60.23
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $80.04Est. basis $60.23
Q1 2026
Unchanged
SEC ref. $64.45Est. basis $60.23
Q4 2025
Unchanged
SEC ref. $62.66Est. basis $60.23
Q3 2025
Unchanged
SEC ref. $73.86Est. basis $60.23
Q2 2025
Unchanged
SEC ref. $62.88Est. basis $60.23
Q1 2025
Unchanged
SEC ref. $58.31Est. basis $60.23
Q4 2024
Unchanged
SEC ref. $56.49Est. basis $60.23
Q3 2024
Reduced 9.6%-1,000,000 reported shares
SEC ref. $83.52Est. basis $60.23
Q2 2024
Unchanged
SEC ref. $57.24Est. basis $60.23
FLUOR CORPFLR
$244.1M
6.2%
+10.7%Est. vs filing basis
Position reduced 1.9%
Reported shares4,658,750
Current price$53.55
SEC reference price$52.39
Estimated filing-based basis$48.38
Position historySEC quarter-end observations
Q2 2026
Reduced 1.9%-88,600 reported shares
SEC ref. $52.39Est. basis $48.38
Q1 2026
Reduced 14.6%-808,550 reported shares
SEC ref. $46.65Est. basis $48.38
Q4 2025
Increased 0.8%+42,220 reported shares
SEC ref. $39.63Est. basis $48.38
Q3 2025
Increased 44.4%+1,694,100 reported shares
SEC ref. $42.07Est. basis $48.44
Q2 2025
New position3,819,580 reported shares
SEC ref. $51.27Est. basis $51.27
CORE NATURAL RESOURCES INCCNR
$182.7M
4.7%
+26.9%Est. vs filing basis
Position increased 22.9%
Reported shares2,283,200
Current price$98.52
SEC reference price$80.02
Estimated filing-based basis$77.64
Position historySEC quarter-end observations
Q2 2026
Increased 22.9%+425,060 reported shares
SEC ref. $80.02Est. basis $77.64
Q1 2026
Reduced 11.5%-242,340 reported shares
SEC ref. $104.73Est. basis $77.10
Q4 2025
Reduced 2.6%-55,160 reported shares
SEC ref. $88.51Est. basis $77.10
Q3 2025
Unchanged
SEC ref. $83.48Est. basis $77.10
Q2 2025
Reduced 2.4%-53,000 reported shares
SEC ref. $69.74Est. basis $77.10
Q1 2025
New position2,208,640 reported shares
SEC ref. $77.10Est. basis $77.10
BRIGHTHOUSE FINL INCBHF
$179.9M
4.6%
-1.7%Est. vs filing basis
Unchanged
Reported shares2,842,100
Current price$50.84
SEC reference price$63.30
Estimated filing-based basis$51.70
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $63.30Est. basis $51.70
Q1 2026
Increased 1.8%+50,000 reported shares
SEC ref. $59.88Est. basis $51.70
Q4 2025
Unchanged
SEC ref. $64.79Est. basis $51.56
Q3 2025
Increased 1.2%+32,003 reported shares
SEC ref. $53.08Est. basis $51.56
Q2 2025
Reduced 1.5%-41,000 reported shares
SEC ref. $53.77Est. basis $51.54
Q1 2025
Reduced 1.2%-34,000 reported shares
SEC ref. $57.99Est. basis $51.54
Q4 2024
Reduced 2.0%-56,952 reported shares
SEC ref. $48.04Est. basis $51.54
Q3 2024
Reduced 2.7%-80,982 reported shares
SEC ref. $45.03Est. basis $51.54
Q2 2024
Reduced 1.6%-48,732 reported shares
SEC ref. $43.34Est. basis $51.54
ACADIA HEALTHCARE COMPANY INACHC
$130.0M
3.3%
+51.0%Est. vs filing basis
Position reduced 2.6%
Reported shares4,400,641
Current price$28.53
SEC reference price$29.53
Estimated filing-based basis$18.90
Position historySEC quarter-end observations
Q2 2026
Reduced 2.6%-117,740 reported shares
SEC ref. $29.53Est. basis $18.90
Q1 2026
Increased 9.6%+397,178 reported shares
SEC ref. $23.39Est. basis $18.90
Q4 2025
Increased 150.9%+2,478,493 reported shares
SEC ref. $14.19Est. basis $18.47
Q3 2025
Increased 89.9%+777,699 reported shares
SEC ref. $24.76Est. basis $24.92
Q2 2025
Increased 615.7%+744,151 reported shares
SEC ref. $22.69Est. basis $25.06
Q1 2025
Reduced 6.0%-7,780 reported shares
SEC ref. $30.32Est. basis $39.65
Q4 2024
New position128,640 reported shares
SEC ref. $39.65Est. basis $39.65
PENN ENTERTAINMENT INCPENN
$125.2M
3.2%
-5.9%Est. vs filing basis
Position reduced 3.0%
Reported shares5,860,270
Current price$17.11
SEC reference price$21.36
Estimated filing-based basis$18.18
Position historySEC quarter-end observations
Q2 2026
Reduced 3.0%-184,170 reported shares
SEC ref. $21.36Est. basis $18.18
Q1 2026
Unchanged
SEC ref. $15.03Est. basis $18.18
Q4 2025
Reduced 10.7%-725,000 reported shares
SEC ref. $14.75Est. basis $18.18
Q3 2025
Reduced 9.7%-725,000 reported shares
SEC ref. $19.26Est. basis $18.18
Q2 2025
Increased 19.6%+1,226,000 reported shares
SEC ref. $17.87Est. basis $18.18
Q1 2025
Increased 9.0%+520,000 reported shares
SEC ref. $16.31Est. basis $18.24
Q4 2024
Increased 2.3%+127,670 reported shares
SEC ref. $19.82Est. basis $18.41
Q3 2024
Increased 10.3%+525,430 reported shares
SEC ref. $18.86Est. basis $18.38
Q2 2024
Increased 11.9%+540,630 reported shares
SEC ref. $19.36Est. basis $18.33
FORTUNE BRANDS INNOVATIONS IFBIN
$123.1M
3.1%
-27.6%Est. vs filing basis
New reported position
Reported shares2,241,875
Current price$39.74
SEC reference price$54.90
Estimated filing-based basis$54.90
Position historySEC quarter-end observations
Q2 2026
New position2,241,875 reported shares
SEC ref. $54.90Est. basis $54.90
PG&E CORPPCG
$111.6M
2.9%
-8.1%Est. vs filing basis
Unchanged
Reported shares6,632,852
Current price$14.03
SEC reference price$16.82
Estimated filing-based basis$15.26
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $16.82Est. basis $15.26
Q1 2026
Reduced 14.8%-1,151,251 reported shares
SEC ref. $17.57Est. basis $15.26
Q4 2025
Increased 22.0%+1,403,250 reported shares
SEC ref. $16.07Est. basis $15.26
Q3 2025
New position6,380,853 reported shares
SEC ref. $15.08Est. basis $15.08
CENTENE CORP DELCNC
$106.0M
2.7%
+46.3%Est. vs filing basis
Position reduced 39.6%
Reported shares1,651,150
Current price$65.40
SEC reference price$64.19
Estimated filing-based basis$44.72
Position historySEC quarter-end observations
Q2 2026
Reduced 39.6%-1,080,660 reported shares
SEC ref. $64.19Est. basis $44.72
Q1 2026
Increased 3.5%+92,390 reported shares
SEC ref. $32.74Est. basis $44.72
Q4 2025
Increased 69.1%+1,078,880 reported shares
SEC ref. $41.15Est. basis $45.14
Q3 2025
Increased 86.0%+721,370 reported shares
SEC ref. $35.68Est. basis $47.89
Q2 2025
Increased 53.3%+291,600 reported shares
SEC ref. $54.28Est. basis $58.39
Q1 2025
Reduced 37.1%-322,930 reported shares
SEC ref. $60.71Est. basis $60.58
Q4 2024
New position870,500 reported shares
SEC ref. $60.58Est. basis $60.58
GRAPHIC PACKAGING HLDG COGPK
$105.2M
2.7%
-47.9%Est. vs filing basis
Position increased 9.4%
Reported shares9,953,430
Current price$9.39
SEC reference price$10.57
Estimated filing-based basis$18.02
Position historySEC quarter-end observations
Q2 2026
Increased 9.4%+853,450 reported shares
SEC ref. $10.57Est. basis $18.02
Q1 2026
Increased 8.1%+684,870 reported shares
SEC ref. $9.94Est. basis $18.72
Q4 2025
Increased 78.8%+3,709,160 reported shares
SEC ref. $15.06Est. basis $19.43
Q3 2025
Unchanged
SEC ref. $19.57Est. basis $22.87
Q2 2025
Increased 349.4%+3,658,850 reported shares
SEC ref. $21.07Est. basis $22.87
Q1 2025
Unchanged
SEC ref. $25.96Est. basis $29.18
Q4 2024
Unchanged
SEC ref. $27.16Est. basis $29.18
Q3 2024
Reduced 25.0%-349,030 reported shares
SEC ref. $29.59Est. basis $29.18
Q2 2024
Reduced 22.3%-400,000 reported shares
SEC ref. $26.21Est. basis $29.18
TD SYNNEX CORPORATIONSNX
$101.9M
2.6%
+55.4%Est. vs filing basis
Position reduced 20.5%
Reported shares381,042
Current price$255.54
SEC reference price$267.34
Estimated filing-based basis$164.41
Position historySEC quarter-end observations
Q2 2026
Reduced 20.5%-98,488 reported shares
SEC ref. $267.34Est. basis $164.41
Q1 2026
Increased 748.9%+423,040 reported shares
SEC ref. $168.71Est. basis $164.41
Q4 2025
Increased 44.7%+17,460 reported shares
SEC ref. $150.23Est. basis $132.20
Q3 2025
Increased 17.3%+5,760 reported shares
SEC ref. $163.75Est. basis $124.14
Q2 2025
Reduced 28.0%-12,945 reported shares
SEC ref. $135.70Est. basis $117.28
Q1 2025
Reduced 14.1%-7,565 reported shares
SEC ref. $103.96Est. basis $117.28
Q4 2024
New position53,780 reported shares
SEC ref. $117.28Est. basis $117.28
TEVA PHARMACEUTICAL INDS LTDTEVA
$97.8M
2.5%
+117.7%Est. vs filing basis
Position reduced 0.8%
Reported shares2,886,059
Current price$36.35
SEC reference price$33.88
Estimated filing-based basis$16.70
Position historySEC quarter-end observations
Q2 2026
Reduced 0.8%-24,670 reported shares
SEC ref. $33.88Est. basis $16.70
Q1 2026
Reduced 4.8%-148,005 reported shares
SEC ref. $30.12Est. basis $16.70
Q4 2025
Reduced 19.1%-720,043 reported shares
SEC ref. $31.21Est. basis $16.70
Q3 2025
Unchanged
SEC ref. $20.20Est. basis $16.70
Q2 2025
Increased 565.0%+3,210,577 reported shares
SEC ref. $16.76Est. basis $16.70
Q1 2025
Increased 21.3%+99,650 reported shares
SEC ref. $15.37Est. basis $16.34
Q4 2024
Increased 44.2%+143,700 reported shares
SEC ref. $22.04Est. basis $16.54
Q3 2024
Unchanged
SEC ref. $18.02Est. basis $14.11
Q2 2024
Unchanged
SEC ref. $16.25Est. basis $14.11
VERSIGENT PLCVGNT
$95.7M
2.4%
+10.4%Est. vs filing basis
New reported position
Reported shares2,277,640
Current price$46.40
SEC reference price$42.01
Estimated filing-based basis$42.01
Position historySEC quarter-end observations
Q2 2026
New position2,277,640 reported shares
SEC ref. $42.01Est. basis $42.01
CAPRI HOLDINGS LIMITEDCPRI
$89.5M
2.3%
-47.9%Est. vs filing basis
Position reduced 2.2%
Reported shares4,820,118
Current price$12.88
SEC reference price$18.57
Estimated filing-based basis$24.71
Position historySEC quarter-end observations
Q2 2026
Reduced 2.2%-110,200 reported shares
SEC ref. $18.57Est. basis $24.71
Q1 2026
Increased 3.4%+162,311 reported shares
SEC ref. $17.62Est. basis $24.71
Q4 2025
Increased 77.4%+2,080,410 reported shares
SEC ref. $24.40Est. basis $24.95
Q3 2025
Reduced 22.8%-791,510 reported shares
SEC ref. $19.92Est. basis $25.37
Q2 2025
Unchanged
SEC ref. $17.70Est. basis $25.37
Q1 2025
Increased 65.4%+1,375,390 reported shares
SEC ref. $19.73Est. basis $25.37
Q4 2024
Increased 93.6%+1,017,072 reported shares
SEC ref. $21.06Est. basis $29.06
Q3 2024
Increased 58.7%+401,875 reported shares
SEC ref. $42.44Est. basis $36.54
Q2 2024
New position684,770 reported shares
SEC ref. $33.08Est. basis $33.08
BKV CORPBKV
$84.7M
2.2%
-10.2%Est. vs filing basis
Position increased 14.8%
Reported shares3,095,173
Current price$24.96
SEC reference price$27.36
Estimated filing-based basis$27.80
Position historySEC quarter-end observations
Q2 2026
Increased 14.8%+399,630 reported shares
SEC ref. $27.36Est. basis $27.80
Q1 2026
Increased 109.3%+1,407,600 reported shares
SEC ref. $28.52Est. basis $27.87
Q4 2025
New position1,287,943 reported shares
SEC ref. $27.15Est. basis $27.15
DHT HOLDINGS INCDHT
$83.2M
2.1%
+95.7%Est. vs filing basis
Position reduced 4.5%
Reported shares5,034,320
Current price$21.43
SEC reference price$16.53
Estimated filing-based basis$10.95
Position historySEC quarter-end observations
Q2 2026
Reduced 4.5%-238,450 reported shares
SEC ref. $16.53Est. basis $10.95
Q1 2026
Reduced 28.4%-2,093,894 reported shares
SEC ref. $18.27Est. basis $10.95
Q4 2025
Reduced 3.3%-254,270 reported shares
SEC ref. $12.21Est. basis $10.95
Q3 2025
Unchanged
SEC ref. $11.95Est. basis $10.95
Q2 2025
Increased 15.3%+1,010,000 reported shares
SEC ref. $10.81Est. basis $10.95
Q1 2025
Increased 26.0%+1,364,950 reported shares
SEC ref. $10.50Est. basis $10.97
Q4 2024
Increased 20.8%+902,704 reported shares
SEC ref. $9.29Est. basis $11.09
Q3 2024
Increased 7.9%+318,940 reported shares
SEC ref. $11.03Est. basis $11.47
Q2 2024
Unchanged
SEC ref. $11.57Est. basis $11.50
CROCS INCCROX
$80.7M
2.1%
+31.1%Est. vs filing basis
Unchanged
Reported shares669,140
Current price$108.83
SEC reference price$120.64
Estimated filing-based basis$83.02
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $120.64Est. basis $83.02
Q1 2026
New position669,140 reported shares
SEC ref. $83.02Est. basis $83.02
ROIVANT SCIENCES LTDROIV
$76.2M
1.9%
+262.9%Est. vs filing basis
Unchanged
Reported shares2,152,669
Current price$40.94
SEC reference price$35.39
Estimated filing-based basis$11.28
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $35.39Est. basis $11.28
Q1 2026
Increased 4.0%+83,360 reported shares
SEC ref. $27.70Est. basis $11.28
Q4 2025
Reduced 9.1%-206,220 reported shares
SEC ref. $21.70Est. basis $10.62
Q3 2025
Reduced 50.0%-2,275,528 reported shares
SEC ref. $15.13Est. basis $10.62
Q2 2025
Reduced 16.4%-890,110 reported shares
SEC ref. $11.27Est. basis $10.62
Q1 2025
Increased 3.2%+170,100 reported shares
SEC ref. $10.09Est. basis $10.62
Q4 2024
Reduced 0.7%-36,973 reported shares
SEC ref. $11.83Est. basis $10.64
Q3 2024
Increased 10.3%+497,080 reported shares
SEC ref. $11.54Est. basis $10.64
Q2 2024
Increased 14.8%+620,470 reported shares
SEC ref. $10.57Est. basis $10.54
SOTERA HEALTH COSHC
$73.4M
1.9%
+13.2%Est. vs filing basis
Position increased 100.2%
Reported shares4,135,515
Current price$18.26
SEC reference price$17.75
Estimated filing-based basis$16.13
Position historySEC quarter-end observations
Q2 2026
Increased 100.2%+2,069,835 reported shares
SEC ref. $17.75Est. basis $16.13
Q1 2026
Increased 347.8%+1,604,410 reported shares
SEC ref. $14.34Est. basis $14.51
Q4 2025
Increased 155.4%+280,690 reported shares
SEC ref. $17.64Est. basis $15.09
Q3 2025
Reduced 22.7%-53,110 reported shares
SEC ref. $15.73Est. basis $11.12
Q2 2025
New position233,690 reported shares
SEC ref. $11.12Est. basis $11.12
Q3 2024
Position exitedLast reported in prior verified quarter
Q2 2024
Unchanged
SEC ref. $11.87Est. basis $12.01
VERSANT MEDIA GROUP INC
$69.2M
1.8%
—Est. vs filing basis
Position reduced 36.5%
Reported shares1,922,172
SEC reference price$36.01
Estimated filing-based basis$37.02
Position historySEC quarter-end observations
Q2 2026
Reduced 36.5%-1,106,443 reported shares
SEC ref. $36.01Est. basis $37.02
Q1 2026
New position3,028,615 reported shares
SEC ref. $37.02Est. basis $37.02
PRIMO BRANDS CORPORATIONPRMB
$69.0M
1.8%
-15.9%Est. vs filing basis
New reported position
Reported shares2,823,660
Current price$20.56
SEC reference price$24.44
Estimated filing-based basis$24.44
Position historySEC quarter-end observations
Q2 2026
New position2,823,660 reported shares
SEC ref. $24.44Est. basis $24.44
DAUCH CORPDCH
$67.2M
1.7%
—Est. vs filing basis
Position increased 96.4%
Reported shares12,395,104
SEC reference price$5.42
Estimated filing-based basis$5.68
Position historySEC quarter-end observations
Q2 2026
Increased 96.4%+6,083,754 reported shares
SEC ref. $5.42Est. basis $5.68
Q1 2026
New position6,311,350 reported shares
SEC ref. $5.93Est. basis $5.93
PAYPAL HLDGS INCPYPL
$61.5M
1.6%
—Est. vs filing basis
New reported position
Reported shares1,424,320
SEC reference price$43.18
Estimated filing-based basis$43.18
Position historySEC quarter-end observations
Q2 2026
New position1,424,320 reported shares
SEC ref. $43.18Est. basis $43.18
SCHEIN HENRY INCHSIC
$60.0M
1.5%
—Est. vs filing basis
Position increased 19.9%
Reported shares718,550
SEC reference price$83.52
Estimated filing-based basis$76.56
Position historySEC quarter-end observations
Q2 2026
Increased 19.9%+119,250 reported shares
SEC ref. $83.52Est. basis $76.56
Q1 2026
Increased 27.7%+130,050 reported shares
SEC ref. $73.70Est. basis $75.17
Q4 2025
New position469,250 reported shares
SEC ref. $75.58Est. basis $75.58
WARNER BROS DISCOVERY INCWBD
$59.9M
1.5%
—Est. vs filing basis
New reported position
Reported shares2,246,180
SEC reference price$26.66
Estimated filing-based basis$26.66
Position historySEC quarter-end observations
Q2 2026
New position2,246,180 reported shares
SEC ref. $26.66Est. basis $26.66
Q1 2026
Position exitedLast reported in prior verified quarter
Q4 2025
New position1,533,080 reported shares
SEC ref. $28.82Est. basis $28.82
LIBERTY GLOBAL LTDLBTYA
$56.4M
1.4%
—Est. vs filing basis
Unchanged
Reported shares4,963,322
SEC reference price$11.37
Estimated filing-based basis$17.16
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $11.37Est. basis $17.16
Q1 2026
Reduced 0.8%-41,110 reported shares
SEC ref. $12.09Est. basis $17.16
Q4 2025
Reduced 4.1%-216,070 reported shares
SEC ref. $11.14Est. basis $17.16
Q3 2025
Unchanged
SEC ref. $11.46Est. basis $17.16
Q2 2025
Unchanged
SEC ref. $10.01Est. basis $17.16
Q1 2025
Increased 34.4%+1,335,244 reported shares
SEC ref. $11.51Est. basis $17.16
Q4 2024
Reduced 8.6%-367,622 reported shares
SEC ref. $12.76Est. basis $19.10
Q3 2024
Increased 108.3%+2,211,300 reported shares
SEC ref. $21.11Est. basis $19.10
Q2 2024
Unchanged
SEC ref. $17.43Est. basis $16.92
ANTERO RESOURCES CORPAR
$55.3M
1.4%
—Est. vs filing basis
Position increased 94.7%
Reported shares1,574,140
SEC reference price$35.14
Estimated filing-based basis$34.79
Position historySEC quarter-end observations
Q2 2026
Increased 94.7%+765,620 reported shares
SEC ref. $35.14Est. basis $34.79
Q1 2026
Reduced 20.3%-205,550 reported shares
SEC ref. $42.44Est. basis $34.46
Q4 2025
New position1,014,070 reported shares
SEC ref. $34.46Est. basis $34.46
STUBHUB HLDGS INCSTUB
$54.5M
1.4%
—Est. vs filing basis
Unchanged
Reported shares4,233,200
SEC reference price$12.87
Estimated filing-based basis$6.24
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $12.87Est. basis $6.24
Q1 2026
New position4,233,200 reported shares
SEC ref. $6.24Est. basis $6.24
RESIDEO TECHNOLOGIES INCREZI
$52.9M
1.4%
—Est. vs filing basis
Position increased 7.9%
Reported shares1,699,590
SEC reference price$31.10
Estimated filing-based basis$33.52
Position historySEC quarter-end observations
Q2 2026
Increased 7.9%+124,640 reported shares
SEC ref. $31.10Est. basis $33.52
Q1 2026
New position1,574,950 reported shares
SEC ref. $33.71Est. basis $33.71
DECKERS OUTDOOR CORPDECK
$50.3M
1.3%
—Est. vs filing basis
Position increased 5.2%
Reported shares506,398
SEC reference price$99.29
Estimated filing-based basis$102.16
Position historySEC quarter-end observations
Q2 2026
Increased 5.2%+25,000 reported shares
SEC ref. $99.29Est. basis $102.16
Q1 2026
Increased 61.1%+182,620 reported shares
SEC ref. $100.09Est. basis $102.31
Q4 2025
New position298,778 reported shares
SEC ref. $103.67Est. basis $103.67
SPECTRUM BRANDS HOLDINGS INCSPB
$48.1M
1.2%
—Est. vs filing basis
Position reduced 13.7%
Reported shares561,438
SEC reference price$85.75
Estimated filing-based basis$59.08
Position historySEC quarter-end observations
Q2 2026
Reduced 13.7%-88,921 reported shares
SEC ref. $85.75Est. basis $59.08
Q1 2026
Reduced 2.0%-13,531 reported shares
SEC ref. $73.70Est. basis $59.08
Q4 2025
New position663,890 reported shares
SEC ref. $59.08Est. basis $59.08
CNH INDL N VCNH
$47.0M
1.2%
—Est. vs filing basis
Unchanged
Reported shares4,188,940
SEC reference price$11.23
Estimated filing-based basis$11.17
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $11.23Est. basis $11.17
Q1 2026
Reduced 27.4%-1,578,600 reported shares
SEC ref. $11.00Est. basis $11.17
Q4 2025
Reduced 2.3%-136,920 reported shares
SEC ref. $9.22Est. basis $11.17
Q3 2025
Reduced 25.0%-1,968,150 reported shares
SEC ref. $10.85Est. basis $11.17
Q2 2025
Reduced 2.5%-203,930 reported shares
SEC ref. $12.96Est. basis $11.17
Q1 2025
Reduced 21.1%-2,158,180 reported shares
SEC ref. $12.28Est. basis $11.17
Q4 2024
Increased 44.2%+3,137,820 reported shares
SEC ref. $11.33Est. basis $11.17
Q3 2024
New position7,096,900 reported shares
SEC ref. $11.10Est. basis $11.10
VIATRIS INCVTRS
$44.0M
1.1%
—Est. vs filing basis
Position increased 52.6%
Reported shares2,773,470
SEC reference price$15.88
Estimated filing-based basis$14.33
Position historySEC quarter-end observations
Q2 2026
Increased 52.6%+955,900 reported shares
SEC ref. $15.88Est. basis $14.33
Q1 2026
New position1,817,570 reported shares
SEC ref. $13.51Est. basis $13.51
Q2 2025
Position exitedLast reported in prior verified quarter
Q1 2025
Increased 3.7%+215,720 reported shares
SEC ref. $8.71Est. basis $11.33
Q4 2024
Reduced 20.4%-1,485,320 reported shares
SEC ref. $12.45Est. basis $11.43
Q3 2024
Reduced 1.7%-129,380 reported shares
SEC ref. $11.61Est. basis $11.43
Q2 2024
Increased 63.8%+2,882,190 reported shares
SEC ref. $10.63Est. basis $11.43
PARAMOUNT SKYDANCE CORPPSKY
$38.7M
1.0%
—Est. vs filing basis
Unchanged
Reported shares3,926,080
SEC reference price$9.86
Estimated filing-based basis$9.02
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $9.86Est. basis $9.02
Q1 2026
New position3,926,080 reported shares
SEC ref. $9.02Est. basis $9.02
PVH CORPORATIONPVH
$38.7M
1.0%
—Est. vs filing basis
New reported position
Reported shares520,800
SEC reference price$74.26
Estimated filing-based basis$74.26
Position historySEC quarter-end observations
Q2 2026
New position520,800 reported shares
SEC ref. $74.26Est. basis $74.26
COMCAST CORP NEWCMCSA
$33.0M
0.8%
—Est. vs filing basis
New reported position
Reported shares1,345,780
SEC reference price$24.55
Estimated filing-based basis$24.55
Position historySEC quarter-end observations
Q2 2026
New position1,345,780 reported shares
SEC ref. $24.55Est. basis $24.55
SLIDE INS HLDGS INCSLDE
$32.7M
0.8%
—Est. vs filing basis
Unchanged
Reported shares1,686,630
SEC reference price$19.37
Estimated filing-based basis$19.01
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $19.37Est. basis $19.01
Q1 2026
Increased 46.7%+536,750 reported shares
SEC ref. $18.00Est. basis $19.01
Q4 2025
New position1,149,880 reported shares
SEC ref. $19.48Est. basis $19.48
TRIPADVISOR INCTRIP
$32.4M
0.8%
-24.5%Est. vs filing basis
Position increased 51.0%
Reported shares2,361,973
Current price$8.82
SEC reference price$13.71
Estimated filing-based basis$11.69
Position historySEC quarter-end observations
Q2 2026
Increased 51.0%+797,277 reported shares
SEC ref. $13.71Est. basis $11.69
Q1 2026
New position1,564,696 reported shares
SEC ref. $10.66Est. basis $10.66
SPDR GOLD TRGLD
$30.7M
0.8%
—Est. vs filing basis
Position reduced 16.3%
Reported shares83,421
SEC reference price$368.38
Estimated filing-based basis$211.69
Position historySEC quarter-end observations
Q2 2026
Reduced 16.3%-16,190 reported shares
SEC ref. $368.38Est. basis $211.69
Q1 2026
Reduced 41.6%-70,950 reported shares
SEC ref. $430.29Est. basis $211.69
Q4 2025
Reduced 2.6%-4,540 reported shares
SEC ref. $396.31Est. basis $211.69
Q3 2025
Increased 3.4%+5,690 reported shares
SEC ref. $355.47Est. basis $211.69
Q2 2025
Reduced 6.0%-10,740 reported shares
SEC ref. $304.83Est. basis $206.86
Q1 2025
Reduced 10.8%-21,790 reported shares
SEC ref. $288.14Est. basis $206.86
Q4 2024
Reduced 3.2%-6,740 reported shares
SEC ref. $242.13Est. basis $206.86
Q3 2024
Increased 3.1%+6,350 reported shares
SEC ref. $243.06Est. basis $206.86
Q2 2024
Reduced 18.0%-44,340 reported shares
SEC ref. $215.01Est. basis $205.72
THE CIGNA GROUPCI
$24.4M
0.6%
—Est. vs filing basis
Unchanged
Reported shares88,400
SEC reference price$275.68
Estimated filing-based basis$330.58
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $275.68Est. basis $330.58
Q1 2026
Reduced 5.7%-5,350 reported shares
SEC ref. $266.75Est. basis $330.58
Q4 2025
Unchanged
SEC ref. $275.23Est. basis $330.58
Q3 2025
Unchanged
SEC ref. $288.25Est. basis $330.58
Q2 2025
New position93,750 reported shares
SEC ref. $330.58Est. basis $330.58
LAKEFRONT BIOTHERAPEUTICS NVLKFT
$14.5M
0.4%
—Est. vs filing basis
Unchanged
Reported shares482,746
SEC reference price$29.98
Estimated filing-based basis$29.27
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $29.98Est. basis $29.27
Q1 2026
Unchanged
SEC ref. $30.00Est. basis $29.27
Q4 2025
Unchanged
SEC ref. $32.70Est. basis $29.27
Q3 2025
Unchanged
SEC ref. $34.64Est. basis $29.27
Q2 2025
Unchanged
SEC ref. $27.99Est. basis $29.27
Q1 2025
Increased 0.7%+3,383 reported shares
SEC ref. $25.12Est. basis $29.27
Q4 2024
Unchanged
SEC ref. $27.50Est. basis $29.30
Q3 2024
Increased 104.1%+244,535 reported shares
SEC ref. $28.79Est. basis $29.30
Q2 2024
Increased 46.9%+75,000 reported shares
SEC ref. $24.78Est. basis $29.83
COYA THERAPEUTICS INCCOYA
$13.7M
0.3%
—Est. vs filing basis
Unchanged
Reported shares2,335,540
SEC reference price$5.85
Estimated filing-based basis$7.79
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $5.85Est. basis $7.79
Q1 2026
Increased 15.3%+309,600 reported shares
SEC ref. $3.94Est. basis $7.79
Q4 2025
Increased 23.0%+379,500 reported shares
SEC ref. $5.80Est. basis $8.38
Q3 2025
Unchanged
SEC ref. $5.70Est. basis $8.97
Q2 2025
Unchanged
SEC ref. $5.75Est. basis $8.97
Q1 2025
Unchanged
SEC ref. $6.47Est. basis $8.97
Q4 2024
Increased 29.2%+372,414 reported shares
SEC ref. $5.73Est. basis $8.97
Q3 2024
Unchanged
SEC ref. $6.45Est. basis $9.92
Q2 2024
Unchanged
SEC ref. $6.06Est. basis $9.92
IMMUNOVANT INCIMVT
$3.6M
0.1%
—Est. vs filing basis
Unchanged
Reported shares93,520
SEC reference price$38.53
Estimated filing-based basis$24.84
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $38.53Est. basis $24.84
Q1 2026
New position93,520 reported shares
SEC ref. $24.84Est. basis $24.84
GOPRO INCGPRO
$1.3M
0.0%
—Est. vs filing basis
Unchanged
Reported shares1,693,860
SEC reference price$0.78
Estimated filing-based basis$2.23
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $0.78Est. basis $2.23
Q1 2026
Unchanged
SEC ref. $0.77Est. basis $2.23
Q4 2025
Unchanged
SEC ref. $1.41Est. basis $2.23
Q3 2025
Reduced 40.0%-1,129,240 reported shares
SEC ref. $2.12Est. basis $2.23
Q2 2025
Unchanged
SEC ref. $0.76Est. basis $2.23
Q1 2025
Unchanged
SEC ref. $0.66Est. basis $2.23
Q4 2024
Unchanged
SEC ref. $1.09Est. basis $2.23
Q3 2024
Unchanged
SEC ref. $1.36Est. basis $2.23
Q2 2024
Unchanged
SEC ref. $1.42Est. basis $2.23
GAIN THERAPEUTICS INCGANX
$1.1M
0.0%
—Est. vs filing basis
Unchanged
Reported shares566,130
SEC reference price$2.03
Estimated filing-based basis$3.77
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $2.03Est. basis $3.77
Q1 2026
Unchanged
SEC ref. $1.94Est. basis $3.77
Q4 2025
Unchanged
SEC ref. $3.22Est. basis $3.77
Q3 2025
Unchanged
SEC ref. $1.77Est. basis $3.77
Q2 2025
Unchanged
SEC ref. $1.80Est. basis $3.77
Q1 2025
Unchanged
SEC ref. $1.91Est. basis $3.77
Q4 2024
Unchanged
SEC ref. $2.16Est. basis $3.77
Q3 2024
Unchanged
SEC ref. $1.78Est. basis $3.77
Q2 2024
Unchanged
SEC ref. $1.28Est. basis $3.77
NUVATION BIO INCNUVB
$198.8K
0.0%
—Est. vs filing basis
Unchanged
Reported shares34,995
SEC reference price$5.68
Estimated filing-based basis$3.64
Position historySEC quarter-end observations
Q2 2026
Unchanged
SEC ref. $5.68Est. basis $3.64
Q1 2026
Unchanged
SEC ref. $4.29Est. basis $3.64
Q4 2025
Unchanged
SEC ref. $8.96Est. basis $3.64
Q3 2025
Unchanged
SEC ref. $3.70Est. basis $3.64
Q2 2025
Unchanged
SEC ref. $1.95Est. basis $3.64
Q1 2025
Unchanged
SEC ref. $1.76Est. basis $3.64
Q4 2024
Unchanged
SEC ref. $2.66Est. basis $3.64
Q3 2024
Unchanged
SEC ref. $2.29Est. basis $3.64
Q2 2024
Unchanged
SEC ref. $2.92Est. basis $3.64

Performance

Estimated 1Y performanceFiling-based estimate

+25.32%

Coverage 100% High coverage

Quarterly performanceBackend-published quarter legs within the 1Y estimate
2025-09-30+6.34%
2025-12-31-0.84%
2026-03-31+1.75%
2026-06-30+16.80%

Displayed legs are backend-ready filing-based estimates. They explain the path of the published 1Y result and are not summed or compounded in the browser.

MethodologyMIL_SEC_PERFORMANCE_V2_EXIT_AWARE_M2M
What this measures

Estimated return from standardized SEC-reported portfolio observations using the approved filing-based methodology. It is not an actual transaction-level or realized investor return.

Portfolio history

Q2 2026
$3.91B
46 positions
Q1 2026
$3.19B
45 positions
Q4 2025
$2.85B
41 positions
Q3 2025
$2.54B
37 positions
Q2 2025
$2.33B
34 positions

Methodology

1. Start with SEC filings

Official Form 13F filings and the canonical MarketInsiderLab filing record are authoritative. Unsupported or unverified data is withheld.

2. Use the verified filing denominator

Portfolio weights use the verified full filing total. Security identity and corporate-action continuity are reconciled before publication.

3. Compare verified quarter-end snapshots

Changes describe differences between verified SEC-reported quarter-end positions. They are not presented as exact buys, sells, trade dates, or execution prices.

4. Keep estimates clearly separated

Estimated filing-based basis and filing-based performance are backend-calculated research estimates, not actual execution prices or audited fund returns.

1-year performance is published only when four consecutive quarterly estimates pass QA and the weakest quarterly leg has at least 70% measurable coverage. Coverage of 90% or more is labeled High coverage; 70–89.9% is labeled Partial estimate. Lower-coverage estimates are withheld.

David Einhorn portfolio FAQ

What is David Einhorn’s largest reported holding?
Green Brick Partners is the largest eligible position in the Jun 30, 2026 filing, valued at about $757.8M, or 19.4% of the complete reported value.
How often is this portfolio updated?
The tracker updates from quarterly Form 13F filings after the manager files with the SEC.
Why does the manager name differ from older filings?
The verified five-year history includes the documented transition from Greenlight Capital Inc. to DME Capital Management, LP.
MarketInsiderLab tracks what public filings actually show.

Research and context — not a recommendation to copy any investor’s trades.

Explore investor portfolios →

David Einhorn portfolio FAQ

What is David Einhorn’s largest reported holding?
Green Brick Partners is the largest eligible position in the Jun 30, 2026 filing, valued at about $757.8M, or 19.4% of the complete reported value.
How often is this portfolio updated?
The tracker updates from quarterly Form 13F filings after the manager files with the SEC.
Why does the manager name differ from older filings?
The verified five-year history includes the documented transition from Greenlight Capital Inc. to DME Capital Management, LP.
MarketInsiderLab tracks what public filings actually show.Research and context — not a recommendation to copy any investor’s trades.
Explore investor portfolios →